Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia. Al-Yafee YA, Al-Ayadhi LY, Haq SH, El-Ansary AK. BMC Neurol. 2011 Nov 4;11:139.
Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results. Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr J.BMC Clin Pharmacol. 2009 Oct 23;9:16.
Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results. Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr J. BMC Clin Pharmacol. 2009 Oct 23;9:17.
-
SourSafety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr J. BMC Clin Pharmacol. 2009 Oct 23;9:16. PMID: 19852789 Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results. Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr J. BMC Clin Pharmacol. 2009 Oct 23;9:17.
The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels. Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Da hr JM. J Toxicol. 2009;2009:532640. Epub 2009 Aug 26.
-
A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder. Kern JK, Geier DA, Adams JB, Geier MR. Biometals. 2010 Dec;23(6):1043-51. Epub 2010 Jun 9.